Načítá se...
Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment
Hu-antigen R (HuR) is an RNA-binding posttranscriptional regulator that belongs to the Hu/ELAV family. HuR expression levels are modulated by a variety of proteins, microRNAs, chemical compounds, or the microenvironment, and in turn, HuR affects mRNA stability and translation of various genes implic...
Uloženo v:
| Vydáno v: | Neoplasia |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Neoplasia Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071540/ https://ncbi.nlm.nih.gov/pubmed/27764700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.09.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|